Christopher Boyes, MD
Vascular Surgery · Palm Beach Gardens, FLNPI 1871810440
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 69.6% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2020 at $22,891 and has fallen 78.8% since, to $4,862 in 2025. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $189.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$41K
- Endologix LLC$4K
- Cook Medical LLC$4K
- Cardiovascular Systems Inc.$3K
- Silk Road Medical, Inc.$2K
- Medtronic$1K
- plus $5K from 23 others
What the payments were for
- Speaking & faculty fees$27,20046%
- Travel & lodging$9,41016%
- Food & beverage$22,29838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 64 | $40,989 |
| Endologix LLC | 21 | $3,721 |
| Cook Medical LLC | 69 | $3,542 |
| Cardiovascular Systems Inc. | 10 | $2,756 |
| Silk Road Medical, Inc. | 25 | $1,957 |
| Medtronic(2 entities) | 38 | $1,407 |
| Philips North America LLC | 16 | $1,234 |
| Bolton Medical Inc | 14 | $618 |
| W. L. Gore & Associates, Inc. | 6 | $543 |
| Boston Scientific | 9 | $457 |
| Johnson & Johnson | 9 | $263 |
| Shockwave Medical, Inc | 6 | $246 |
| Abbott | 3 | $206 |
| Atrium Medical Corporation | 1 | $199 |
| Cvrx, Inc. | 1 | $146 |
| EKOS Corporation | 1 | $139 |
| Getinge USA Sales, LLC | 3 | $137 |
| Tactile Systems Technology Inc | 4 | $105 |
| Janssen Scientific Affairs, LLC | 1 | $53 |
| Lemaitre Vascular, Inc. | 1 | $35 |
| Terumo Medical Corporation | 1 | $26 |
| Atricure, Inc. | 1 | $24 |
| Cordis US CORP. | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| Angiodynamics, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Urgo Medical North America, LLC | 1 | $14 |
| Sirtex Medical Inc | 1 | $7 |
| Asahi Intecc USA, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo$29,072
- Indigo System$8,956
- Penumbra Ruby Coil$3,262
- Peripheral Orbital Atherectomy System$2,268
- Alto Abdominal Stent Graft System$1,632
- Artemis$1,518
- ENDOCROSS Device$1,151
- Torus Stent Graft System$1,151
- ENROUTE Transcarotid Neuroprotection System$1,146
- ENROUTE Transcarotid Stent System$1,035
- ENHANCE Transcarotid Peripheral Access Kit$1,035
- ENROUTE 0.014 Guidewire$1,035
- AFX2 Bifurcated Endograft System$756
- Penumbra System$511
- Zilver Vena$451
- Cook Medical Zilver PTX$359
- ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM$349
- Diamondback Peripheral$244
- IGT D Peripheral$234
- Zilver PTX$211
How this compares
$58,908 in reported general payments places this provider in the 90th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 55 | $44,751 |
| EliquisApixaban | 20 | $12,892 |
| ClopidogrelClopidogrel Bisulfate | 191 | $1,955 |
| Rosuvastatin Calcium | 40 | $523 |
| Atorvastatin Calcium | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $263 | $44,75155 claims |
| PfizerEliquis | $16 | $12,89220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Palm Beach Gardens
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
- Joseph RicottaDelray Beach$156K
- Murray ShamesTampa$144K
- K Dean ArnaoutakisTampa$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.